Inhaled zanamivir, a potent and selective inhibitor of influenza A and B virus neuraminidases, is effective in treating acute influenza in adults and adolescents. 8–10 In addition, seasonal ...

Cite this: Zanamivir for the Treatment of Clinically Diagnosed Influenza in Clinical Practice: Results of the Valuable-Insights-From-Patients Study - Medscape - Nov 01, 2000.

Cite this: Zanamivir, a New Targeted Therapy in the Treatment of Influenza - Medscape - Feb 01, 2000.

The large study enrolled 865,032 outpatients treated with inhaled zanamivir (n = 595,897) or oral oseltamivir (269,135) within 48 hours of being diagnosed with influenza.

Correspondence Zanamivir to Prevent Influenza Published February 15, 2001 N Engl J Med 2001;344: 528 - 530 DOI: 10.1056/NEJM200102153440714 ...

Review the side-effects of Zanamivir as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Zanamivir is taken as an inhaler. The nature of the inhaler is that it's more difficult to use, and there are some contraindications, for example, in younger children, in pregnant women, and in ...

Naoki Kawai, Hideyuki Ikematsu, Nobuo Hirotsu, Tetsunari Maeda, Takashi Kawashima, Osame Tanaka, Satoshi Yamauchi, Kenichi Kawamura, Shinro Matsuura, Mika Nishimura, Norio Iwaki, Seizaburo Kashiwagi, ...

Review of NICE Technology Appraisal Guidance No.158; Oseltamivir, amantadine and zanamivir for the prophylaxis of influenza, and No.168; Amantadine, oseltamivir and zanamivir for the treatment of ...

The molecular basis for oseltamivir (Tamiflu) resistance in some clinical isolates of the H5N1 influenza virus has been identified as a mutation in the drug's target, viral neuraminidase. However ...